Issues: Vax Specific

Anthrax

Hepatitis B

Hib

Influenza

Lyme Disease
Meningococcal

MMR    

Polio

Rotavirus

● Smallpox

Tdap/Td

Varicella

Yellow Fever

 

Issues: Misc

Exemptions

Legislation 

New Vax Status

Thimerosal

Independent Vax  Safety Board

 

Vaccine Info

2008 Schedule

ACIP Recs

Components
IOM Reports

● Vax Injury Comp Program
Manufacturer Links

Package Inserts

Reporting AEs

Thimerosal Table

VAERS

VISs

 

Links

Search

About IVS

Faculty Biographies

Publications

Donations

 

Email IVS

 

Disclaimers & Privacy

 

Institute for Vaccine Safety

Johns Hopkins Bloomberg School of Public Health

615 N. Wolfe Street

Room W5041

Baltimore, MD 21205

www.vaccinesafety.edu

 

 

Catch-up Immunization Schedule
Ages 7 - 18 Years

UNITED STATES • 2008

 

 Vaccine
Min Age
for Dose 1
Minimum Interval Between Doses
Doses 1 and 2 Doses 2 and 3 Doses 3 and 4
Tetanus, Diphtheria/Diphtheria, Tetanus, Pertussis1
7 yrs1 4 wks 4 wks
if age at dose 1
< 12 mos

6 mos
if age at dose 1
≥ 12 mos

6 mos
if age at dose 1
< 12 mos
9 yrs 4 wks 12 wks  
12 mos 6 mos    
Birth 4 wks 8 wks  
6 wks 4 wks 4 wks 4 wksnote
12 mos 4 wks    
12 mos 4 wks
if age at dose 1
≥ 13 yrs

3 mos
if age at dose 1 < 13 yrs

   

 

 
 
1. Tetanus and diphtheria toxoids vaccine (Td) and tetanus and diphtheria toxoids and acellular pertussis vaccine (Tdap).
  • Tdap should be substituted for a single dose of Td in the primary catch-up series or as a booster
    if age appropriate; use Td for other doses.
  • A 5-year interval from the last Td dose is encouraged when Tdap is used as a booster dose. A booster (fourth) dose is needed if any of the previous doses were administered at younger than 12 months of age. Refer to ACIP recommendations for further information. See MMWR 2006;55(No. RR-3).

2. Human papillomavirus vaccine (HPV).

  • Administer the HPV vaccine series to females at age 13–18 years if not previously vaccinated.

3. Hepatitis A vaccine (HepA).

  • HepA is recommended for certain groups of children, including in areas where vaccination programs target older children. See MMWR 2006;55(No. RR-7):1-23.

4. Hepatitis B vaccine (HepB).

  • Administer the 3-dose series to those who were not previously vaccinated.
  • A 2-dose series of Recombivax HB® is licensed for children aged 11–15 years.

5. Inactivated poliovirus vaccine (IPV).

  • For children who received an all-IPV or all-oral poliovirus (OPV) series, a fourth dose is not necessary if the third dose was administered at age 4 years.
  • If both OPV and IPV were administered as part of a series, a total of 4 doses should be administered, regardless of the child’s current age.
  • IPV is not routinely recommended for persons 18 years.

6. Measles, mumps, and rubella vaccine (MMR).

  • The second dose of MMR is recommended routinely at age 4-6 years but may be administered earlier if desired.
  • If not previously vaccinated, administer 2 doses of MMR during any visit, with 4 weeks between the doses.

7. Varicella vaccine.

  • The second dose of varicella vaccine is recommended routinely at age 4-6 years but may be administered earlier if desired.
  • Do not repeat the second dose in persons aged >13 years if administered 28 or more days after the first dose.
 

This page was last updated on January 30, 2008